Chenyang Ye

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Basal Cell Carcinoma

Locally Advanced

Top Venues

Signal transduction and targeted therapy

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Wang, Chenyang Ye, Xiangjie Xue, Mingjun Xie, Yicheng Zhi, Xiao Feng, Pengcheng Zhao, Jichun Zhou, Mi Mi, Jinrui Li, Qinhao Gu, Ye Zhao, Jiaxin Chen, Yi Zhou, Yanan Xue, Zexin Fu, Liuyi Zhou, Lulu Chen, Lei Pan, Yi Sun, Linbo Wang, Sufan Wu, Yong He, Ji Wang
3D-Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Xiangjie Xue, Ji Wang, Chenyang Ye
Landscape of antitumor CD4 + T cells in melanoma:unraveling novel HLA class II-driven immune escape. Signal transduction and targeted therapy 8 (1) (2023)
Xiangjie Xue, Ji Wang, Chenyang Ye
Landscape of antitumor CD4 + T cells in melanoma:unraveling novel HLA class II-driven immune escape. Signal transduction and targeted therapy 8 (1) (2023)
Xiangjie Xue, Ji Wang, Chenyang Ye
Landscape of antitumor CD4 + T cells in melanoma:unraveling novel HLA class II-driven immune escape. Signal transduction and targeted therapy 8 (1) (2023)
Xiangjie Xue, Ji Wang, Chenyang Ye
Landscape of antitumor CD4 + T cells in melanoma:unraveling novel HLA class II-driven immune escape. Signal transduction and targeted therapy 8 (1) (2023)
Xiangjie Xue, Ji Wang, Chenyang Ye
Landscape of antitumor CD4 + T cells in melanoma:unraveling novel HLA class II-driven immune escape. Signal transduction and targeted therapy 8 (1) (2023)
Mi Mi, Chenyang Ye, Ying Yuan
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair-deficient, locally advanced rectal cancer. Signal transduction and targeted therapy 7 (1) (2022)